Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-073250
Filing Date
2024-06-13
Accepted
2024-06-13 19:58:48
Documents
1
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4403
  Complete submission text file 0000950170-24-073250.txt   5803
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Issuer) CIK: 0001538210 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NEXIMMUNE, INC. 9119 GAITHER ROAD GAITHERSBURG MD 20877
Business Address
Jones Kristi (Reporting) CIK: 0001843849 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40045 | Film No.: 241042708